Improvement of renal dysfunction by conversion from calcineurin inhibitors to sirolimus after heart transplantation

Journal of Heart and Lung Transplantation

Volumn 24, Issue 11, 2005, Pages 1863-1867

  Hunt, Judson ^a   Lerman, Mark ^a   Magee, Mitchell J ^a   Dewey, Todd M ^a   Herbert, Morley ^a   Mack, Michael J ^a,b  

^a MEDICAL CITY DALLAS HOSPITAL   (United States)

^b CSANT PA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CREATININE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN;

ACNE; ADOLESCENT; ADULT; AGED; ARTICLE; CARDIAC GRAFT REJECTION; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIARRHEA; DRUG EFFECT; DRUG ERUPTION; DRUG FATALITY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HEART TRANSPLANTATION; HUMAN; HYPERLIPIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DYSFUNCTION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; NEPHROTOXICITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STOMATITIS;

ADOLESCENT; ADULT; AGED; CALCINEURIN; CREATININE; DISEASE PROGRESSION; FEMALE; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; SIROLIMUS; TIME FACTORS;

EID: 27844587421     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2005.02.018     Document Type: Article

References (34)

1. L. Backman, J.M. Morales Is nonnephrotoxic immunosuppression a possibility? Transplantation 69 suppl 2000 SS27 SS30
2. J.D. Gummert, T. Ikonen, R.E. Morris Newer immunosuppressive drugs a review J Am Soc Nephrol 10 1999 1366 1380
3. G. Parry, B. Meiser, G.R. Bago The clinical impact of cyclosporine nephrotoxicity in heart transplantation Transplantation 69 suppl 2000 SS23 SS26
4. R.G. Woolfson, G.H. Neild Cyclosporine nephrotoxicity following cardiac transplantation Nephrol Dial Transplant 12 1997 2054 2056
5. S. Vitko, O. Viklicky Cyclosporine renal dysfunction Transplant Proc 36 suppl 2004 S243 S247
6. M. Tinawi, L. Miller, B. Bastani Renal function in cardiac transplant recipients retrospective analysis of 133 consecutive patients in a single center Clin Transplant 11 1997 1 8
7. P. Ruggenenti, N. Perico, C.S. Amuchastegui Following an initial decline, glomerular filtration rate stabilizes in heart transplant patients on chronic cyclosporine Am J Kidney Dis 24 1994 549 553
8. M. Waser, M. Maggiorini, U. Binswanger Irreversibility of cyclosporine-induced renal function impairment in heart transplant recipients J Heart Lung Transplant 12 1993 846 850
9. A. Greenberg, J.W. Edgel, M.E. Thompson Early and late forms of cyclosporine nephrotoxicity studies in cardiac transplant recipients Am J Kidney Dis 9 1987 12 22
10. R. Zietse, A.H. Balk, M.A. Dorpel Time course of decline in renal function in cyclosporine-treated heart transplant recipients Am J Nephrol 14 1994 1 5
11. D.J. Goldstein, N. Zuech, V. Sehgal Cyclosporine-associated end-stage nephropathy after cardiac transplantation incidence and progression Transplantation 63 1997 664 668
12. S. Veillon, S. Caillard, E. Epailly Chronic renal failure after cardiac transplantation predictive factors and influence on mortality - results of a monocenter study in 141 patients Transplant Proc 34 2002 2819 2820
13. J.M. Grinyo Progress with cyclosporine-sparing regimens Transplant Proc 31 suppl 8A 1999 11S 16S
14. J. Groetzner, I. Kaczmarek, P. Landwehr Renal recovery after conversion to a calcineurin inhibitor-free immunosuppression in late cardiac transplant recipients Eur J Cardiothorac Surg 25 2004 333 341
15. A.H. Cotterell, R.A. Fisher, A.L. King Calcineurin inhibitor-induced chronic nephrotoxicity in liver transplant patients is reversible using a rapamycin as the primary immunosuppressive agent Clin Tranplant 16 suppl 7 2002 49 51
16. D.E. Hricik Use of sirolimus to facilitate cyclosporine avoidance or steroid withdrawal in kidney transplant recipients Transplant Proc 35 suppl 3 2003 73S 78S
17. F. Citterlo, M.C. Scata, P. Violi Rapid conversion to sirolimus for chronic progressive deterioration of the renal function in kidney allograft recipients Transplant Proc 35 2003 1292 1294
18. E.J. Kaplinksy, N. Maniot, J. Roca Sirolimus in heart transplantation a single center initial experience Transplant Proc 35 2003 1978 1980
19. M. Zakliczynski, J. Nozynski, H. Zakliczynska, P. Rozentryt, M. Zembala Deterioration of renal function after replacement of cyclosporine with sirolimus in five patients with severe renal impairment late after heart transplantation Transplant Proc 35 2003 2331 2332
20. J. Groetzner, I. Kaczmarek, P. Landwehr Renal recovery after conversion to a calcineurin inhibitor-free immunosuppression in late cardiac transplant recipients Eur J Cardiothorac Surg 25 2004 333 341
21. G.L. Snell, B.J. Levvey, W. Chin Sirolimus allows renal recovery in lung and heart transplant recipients with chronic renal impairment J Heart Lung Transplant 21 2002 540 546
22. A. Greenberg, M.E. Thompson, B.J. Griffith Cyclosporine nephrotoxicity in cardiac allograft patients - a seven-year follow-up Transplantation 50 1990 589 593
23. B.D. Myers, L. Newton, C. Boshkos Chronic injury of human renal microvessels with low-dose cyclosporine therapy Transplantation 46 1988 694 703
24. B.D. Myers, R. Sibley, L. Newton The long-term course of cyclosporine-associated chronic nephropathy Kidney Int 33 1988 590 600
25. M.E. Falkenhain, F.G. Cosio, D.D. Sedmak Progressive histologic injury in kidneys from heart and liver transplant recipients receiving cyclosporine Transplantation 62 1996 364 370
26. T. Bertani, P. Ferrazzi, A. Schieppati Nature and extent of glomerular injury induced by cyclosporine in heart transplant patients Kidney Int 40 1991 243 250
27. T. Van Gelder, A.H.M.M. Balk, R. Zietse Renal insufficiency after heart transplantation a case-control study Nephrol Dial Transplant 13 1998 2322 2326
28. B. Lindelow, C.H. Bergh, H. Herlitz, F. Waagstein Predictors and evolution of renal function during 9 years following heart transplantation J Am Soc Nephrol 11 2000 951 957
29. M.R. Vossler, H. Ni, W. Toy, R.E. Hershberger Preoperative renal function predicts development of chronic renal insufficiency after orthotopic heart transplantation J Heart Lung Transplant 21 2002 874 881
30. C. Esposito, L. Semeraro, N. Bellotti Risk factors for chronic renal dysfunction in cardiac allograft recipients Nephron 84 2000 21 28
31. S.N. Sehgal Rapamune (RAPA, rapamycin, sirolimus) mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression Clin Biochem 31 1998 335 340
32. D. Mancini, S. Pinney, D. Burkhoff Use of rapamycin slows progression of cardiac transplantation vasculopathy Circulation 108 2003 48 53
33. T. Tedoriya, A.M. Keogh, K. Kusano Reversal of chornic cyclosporine nephrotoxicity after heart transplantation - potential role of mycophenolate mofetil J Heart Lung Transplant 21 2002 976 982
34. D.A. Baran, I.D. Galin, A.L. Gass Calcineurin inhibitor-associated early renal insufficiency in cardiac transplant recipients; risk factors and strategies for prevention and treatment Am J Cardiovasc Drugs 4 2004 21 29